The results of pharmacist consultations for the patient's health and health care system economy.

Not Applicable

• Conditions: Hypertension; Diseases of the circulatory system; C14.907.489

• Registration Number: RBR-8pchqf
• Lead Sponsor: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-25
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Hypertension, over 18 years in treatment.

Exclusion Criteria

Previously be gone, cognitive impairment, pregnant and lactating.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected outcome: The reduction in systolic blood pressure of 5-10 mmHg in one year of intervention.<br><br>By analyzing the drugs used by the patient, the pharmacist verified the presence of possible drug related problems (DRP). On detecting a DRP, the pharmacist completed a form containing the breakdown of the drug in question (name, presentation, daily dose, dosage form and administration time), classified the DRP according to the PWDT, described the intervention to be performed and the proposed outcomes to be achieved with the intervention, established the form of monitoring of these results, designated the deadline for re-evaluation of clinical outcome and filled in the field concerning the adherence of intervention by the prescriber. In addition, the patient was informed and educated about the new behaviors in their pharmacotherapy when there was adherence by the physician.<br>;Outcome found: reduction of 17.8 mmHg and 7.1 mmHg in systolic and diastolic pressure, respectively.